Cadila Healthcare (BSE: 532321) is an Indian pharmaceutical company headquartered at Ahmedabad in Gujarat state of western India. The company is the fourth largest pharmaceutical company in India, with INR 54.7 Billion revenue (2015). It is a significant manufacturer of generic drugs. Cadila was founded in 1952 by Ramanbhai Patel (1925–2001), formerly a lecturer in the L.M. College of Pharmacy, and his business partner Bhavya Modi. It evolved over the next four decades into an established pharmaceutical company. In 1995 the Patel and Modi families split, with the Modi familys share being moved into a new company called Cadila Pharmaceuticals Ltd. and Cadila Healthcare became the Patel familys holding company. Cadila Healthcare had its initial public offering on the Bombay Stock Exchange in 2000 as stock code 532321.